RBP4 and metabolic syndrome: Retinol-binding protein 4 (RBP4), which is synthesized by the liver and released into the blood, has been identified to be related to the development of metabolic syndrome, atherosclerosis, and hypothyroidism, owing to its interaction with retinol, thyroxine transporter, and cell surface receptors (15,16).